arrow
D

Diether Lambrechts

KU Leuven
H指数:122
被引数:6.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of STYXL1 as novel susceptibility gene for anthracycline-induced cardiotoxicity in breast cancer patients

鉴定STYXL1作为乳腺癌患者蒽环类药物诱导的心脏毒性的新型易感基因

2026-10-270
PRE
Evaluating the NFPp10a/NF5310 glioblastoma model as a faithful avatar for screening tumour microenvironment–targeted therapies

评估NFPp10a/NF5310胶质母细胞瘤模型作为忠实替身用于筛选肿瘤微环境靶向疗法

2026-09-040
OAAI
Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes

重症肺炎中的肺炎症以分区域且机制不同的亚表型为特征

2026-06-230
OAAI
Pan-cancer single-cell atlases of mouse and human tumor-associated dendritic cells

小鼠和人类肿瘤相关树突状细胞的泛癌单细胞图谱

2026-05-300
OAAI
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis

整合多组学分析揭示代谢功能障碍相关脂肪性肝炎进展过程中巨噬细胞的特异性改变

2026-05-180
OAAI
A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer

一种基于机器学习的多模态数据融合方法流程,用于贝伐珠单抗治疗转移性结直肠癌的预后风险分析

2026-04-010
OAAI
Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma

在局限性和转移性透明细胞肾细胞癌中Clearseq1-4肿瘤微环境分类的预后和预测价值

2026-04-010
PRE
Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis

作者更正: PHGDH异质性增强癌细胞的传播和转移

Nature
IF48.5
2026-02-050
PRE
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain

贝伐珠单抗用于染色体不稳定性转移性结直肠癌:德国、爱尔兰和西班牙一种新型精准治疗方法的成本效益分析

2026-02-040
PRE
ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer

ctDNA在转移性乳腺癌患者七种体液中的检测性与代表性

2025-12-020
OAAI
Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response

单细胞图谱分析:与免疫检查点疗法反应相关的选择性剪接

2025-11-260
PRE
Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial

不可切除的非转移性局部晚期胰腺癌在行手术治疗联合微波消融、durvalumab和tremelimumab后的无进展生存期:二期非随机前瞻性临床研究

2025-11-180
OAAI
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction

欧洲血统人群的多基因得分分布差异: 对乳腺癌风险预测的影响

2024-12-290
OAAI
Germline copy number variants and endometrial cancer risk

生殖细胞拷贝数变异与子宫内膜癌风险

2024-11-040
OAAI